ReviewCholecystokinin and gastrin receptors targeting in gastrointestinal cancer

Add time:08/27/2019    Source:sciencedirect.com

Cholecystokinin and Gastrin are amongst the first gastrointestinal hormone discovered. In addition to classical actions (contraction of gallbladder, growth and secretion in the stomach and pancreas), these also act as growth stimulants for gastrointestinal malignancies and cell lines. Growth of these tumours is inhibited by antagonists of the cholecystokinin and gastrin receptors. These receptors provides most promising approach in clinical oncology and several specific radiolabelled ligands have been synthesized for specific tumour targeting and therapy of tumours overexpressing these receptors. Therefore, definition of the molecular structure of the receptor involved in the autocrine/paracrine loop may contribute to novel therapies for gastrointestinal cancer. Hence, this review tries to focus on the role and distribution of these hormones and their receptors in gastrointestinal cancer with a brief talk about the clinical trial using available agonist and antagonist in gastrointestinal cancers.

We also recommend Trading Suppliers and Manufacturers of cholecystokinin 9 (cas 108050-84-6). Pls Click Website Link as below: cas 108050-84-6 suppliers

Prev:Nonsulfated cholecystokinins in the small intestine of pigs and rats
Next:Research ArticleSecretion of a gastrointestinal hormone, cholecystokinin, by hop-derived bitter components activates sympathetic nerves in brown adipose tissue☆)